palmidrol has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gagliano, C | 1 |
| Ortisi, E | 1 |
| Pulvirenti, L | 1 |
| Reibaldi, M | 1 |
| Scollo, D | 1 |
| Amato, R | 1 |
| Avitabile, T | 1 |
| Longo, A | 1 |
1 trial available for palmidrol and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial.
Topics: Administration, Oral; Aged; Amides; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method | 2011 |